Age-related macular degeneration (AMD) is the leading cause of severe vision loss in older adults, yet the greatest opportunity to preserve vision often occurs before patients ever reach ophthalmology. From the AAVBC's perspective, value-based AMD care begins in primary care by recognizing that progressive vision changes are not an inevitable consequence of aging, identifying patients at risk for conversion to neovascular (wet) AMD, and ensuring rapid retinal evaluation when new symptoms emerge. Because treatment delays can permanently reduce visual recovery, timely recognition, precise documentation, and coordinated referral are high-value clinical interventions—not administrative tasks.
AAVBC's Adult Macular Degeneration Quick Reference Guide moves beyond guideline summaries to highlight the practical decisions that most influence outcomes and resource stewardship. It addresses common documentation and coding pitfalls, ICD-10 staging and laterality specificity, MEAT standards, HCC risk adjustment, and evidence-based referral pathways, while emphasizing underrecognized opportunities for primary care to improve long-term outcomes through smoking cessation, cardiovascular risk optimization, appropriate AREDS2 use, assessment of falls, depression, transportation and treatment barriers, and support for cost-conscious, patient-centered care. The guide also explores emerging value-based strategies—including home monitoring for appropriate high-risk patients and clinically appropriate lower-cost anti-VEGF options—that can improve access, adherence, and preservation of functional independence.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of adult macular degeneration — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
Age-related macular degeneration (AMD) is the leading cause of severe vision loss in older adults, yet the greatest opportunity to preserve vision often occurs before patients ever reach ophthalmology. From the AAVBC's perspective, value-based AMD care begins in primary care by recognizing that progressive vision changes are not an inevitable consequence of aging, identifying patients at risk for conversion to neovascular (wet) AMD, and ensuring rapid retinal evaluation when new symptoms emerge. Because treatment delays can permanently reduce visual recovery, timely recognition, precise documentation, and coordinated referral are high-value clinical interventions—not administrative tasks.
AAVBC's Adult Macular Degeneration Quick Reference Guide moves beyond guideline summaries to highlight the practical decisions that most influence outcomes and resource stewardship. It addresses common documentation and coding pitfalls, ICD-10 staging and laterality specificity, MEAT standards, HCC risk adjustment, and evidence-based referral pathways, while emphasizing underrecognized opportunities for primary care to improve long-term outcomes through smoking cessation, cardiovascular risk optimization, appropriate AREDS2 use, assessment of falls, depression, transportation and treatment barriers, and support for cost-conscious, patient-centered care. The guide also explores emerging value-based strategies—including home monitoring for appropriate high-risk patients and clinically appropriate lower-cost anti-VEGF options—that can improve access, adherence, and preservation of functional independence.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of adult macular degeneration — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
